MC
Maverick Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,983
| Closed | -$752K | – | 324 |
|
|
2021
Q3 | $752K | Sell |
3,983
-288,700
| -99% | -$54.5M | 0.01% | 376 |
|
|
2021
Q2 | $49.6M | Sell |
292,683
-503,551
| -63% | -$85.4M | 0.47% | 38 |
|
|
2021
Q1 | $112M | Sell |
796,234
-188,268
| -19% | -$26.6M | 1.04% | 18 |
|
|
2020
Q4 | $128M | Buy |
984,502
+17,041
| +2% | +$2.21M | 2.05% | 18 |
|
|
2020
Q3 | $141M | Sell |
967,461
-146,147
| -13% | -$21.3M | 2.62% | 11 |
|
|
2020
Q2 | $165M | Sell |
1,113,608
-226,097
| -17% | -$33.5M | 3.47% | 10 |
|
|
2020
Q1 | $146M | Sell |
1,339,705
-921,192
| -41% | -$100M | 3.08% | 11 |
|
|
2019
Q4 | $260M | Sell |
2,260,897
-961,916
| -30% | -$111M | 3.79% | 7 |
|
|
2019
Q3 | $259M | Sell |
3,222,813
-1,013,203
| -24% | -$81.5M | 3.81% | 7 |
|
|
2019
Q2 | $307M | Buy |
4,236,016
+1,025,629
| +32% | +$74.4M | 4.45% | 7 |
|
|
2019
Q1 | $300M | Buy |
3,210,387
+406,436
| +14% | +$38M | 3.98% | 4 |
|
|
2018
Q4 | $204M | Buy |
2,803,951
+1,291,887
| +85% | +$94.2M | 3% | 10 |
|
|
2018
Q3 | $132M | Buy |
1,512,064
+830,710
| +122% | +$72.7M | 1.65% | 22 |
|
|
2018
Q2 | $67.1M | Buy |
+681,354
| New | +$67.1M | 0.78% | 27 |
|